Teza Capital Management LLC Cytokinetics Inc Transaction History
Teza Capital Management LLC
- $746 Million
- Q1 2024
A detailed history of Teza Capital Management LLC transactions in Cytokinetics Inc stock. As of the latest transaction made, Teza Capital Management LLC holds 7,952 shares of CYTK stock, worth $448,572. This represents 0.07% of its overall portfolio holdings.
Number of Shares
7,952
Previous 2,762
187.91%
Holding current value
$448,572
Previous $230,000
142.17%
% of portfolio
0.07%
Previous 0.04%
Shares
6 transactions
Others Institutions Holding CYTK
# of Institutions
461Shares Held
107MCall Options Held
7.2MPut Options Held
6.2M-
Black Rock Inc. New York, NY12.4MShares$700 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA10MShares$564 Million0.01% of portfolio
-
T. Rowe Price Investment Management, Inc. Baltimore, MD5.12MShares$289 Million0.22% of portfolio
-
Bank Of America Corp Charlotte, NC4.78MShares$270 Million0.03% of portfolio
-
State Street Corp Boston, MA4.52MShares$255 Million0.01% of portfolio
About CYTOKINETICS INC
- Ticker CYTK
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 94,144,096
- Market Cap $5.31B
- Description
- Cytokinetics, Incorporated, a late-stage biopharmaceutical company, focuses on discovering, developing, and commercializing muscle activators and inhibitors as potential treatments for debilitating diseases. The company develops small molecule drug candidates primarily engineered to impact muscle function and contractility. Its drug candidates i...